Prostate Delineation: High Quality Volume CT

NCT ID: NCT01878773

Last Updated: 2017-08-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2017-08-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will look at how feasible it is to use a certain type of Computed Tomography (CT) to scan prostate cancer, called a high quality volume CT scan. It is hoped that this technique will help doctors provide a higher-quality image of the prostate cancer, making it easier to plan the area that will be treated. Using this type of CT scan will also lessen the amount of time patients spend in the scanner.

This study will not offer patients a different treatment for their prostate cancer. Patients will receive the most appropriate standard treatment whether or not they are in this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Quality Volume CT Scan; MRI Scan

Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI Scan.

Group Type OTHER

High Quality Volume CT Scan; MRI Scan

Intervention Type OTHER

Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI scan.

\--------------------------------------------------------------------------------

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Quality Volume CT Scan; MRI Scan

Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI scan.

\--------------------------------------------------------------------------------

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. At least 18 years old
2. Subjects undergoing radical external beam radiotherapy for prostate cancer
3. Ability to provide written informed consent

Exclusion Criteria

1. Age ≤ 18 years
2. Subjects not suitable for MRI scanning
3. 3 usable image sets not obtained during treatment planning scans.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Princess Margaret Hospital, Canada

OTHER

Sponsor Role collaborator

University Health Network, Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Health Network, The Princess Margaret

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UHN REB 12-5229-CE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Imaging of High Grade Prostate Cancer
NCT02177526 TERMINATED NA
Tumor TARGET Prostate Cancer
NCT01802242 ACTIVE_NOT_RECRUITING NA